不同专科培训路径对肝胆胰外科肿瘤手术结局的影响
该研究基于2016–2021年Medicare数据,分析1030名完成不同专科培训的外科医生所行15411例肝胆胰肿瘤手术的教科书结局(TO)。结果示肝胆胰专科培训毕业生的TO率为47.7%,高于肿瘤外科毕业生的45.2%和移植外科毕业生的42.8%(P=0.001),差异主要源于胰腺切除术,且集中于职业早期和中期。
要点
- 肝胆胰专科培训毕业生行胰腺切除术的TO率优于其他路径,差异有统计学意义。
- 职业早期和中期,专科培训毕业生TO概率更高;晚期则无差异。
- 应加强肿瘤外科方向学员的肝胆胰手术暴露与培训。
核心结论
- 完成肝胆胰专科培训的外科医生行肝胆胰肿瘤手术的教科书结局率更高。
- 该优势在职业早期(第1–7年,P=0.032)和中期(第8–14年,P<0.001)显著,晚期(≥15年,P=0.257)无差异。
研究设计与样本
- 回顾性队列研究,使用2016–2021年Medicare索赔数据,纳入15411例肝胆胰肿瘤手术,由1030名肝胆胰外科医生完成。
主要发现
- 总体15411例手术中,胰腺切除术11003例(71.4%),肝切除术4408例(28.6%)。
- 9390例(60.9%)由肿瘤外科毕业生手术,2315例(15.0%)由肝胆胰专科毕业生手术,3706例(24.1%)由移植外科毕业生手术。
- 肝胆胰专科毕业生患者Charlson评分>5的比例为44.8%,高于肿瘤外科毕业生的38.1%(P<0.001);急诊手术比例为7.7%,高于6.1%(P<0.001)。
- 调整后TO率:肝胆胰专科47.7%,肿瘤外科45.2%(差值2.5%),移植外科42.8%(差值4.9%,P=0.001)。
- TO差异主要归因于胰腺切除术(P<0.001),肝切除术无显著差异(P=0.758)。
临床怎么用
- 对计划从事肝胆胰外科的肿瘤外科方向学员,应强化肝胆胰手术暴露与专项培训。
- 选择肝胆胰肿瘤手术医生时,可考虑其专科培训路径,尤其是职业早中期的肝胆胰专科毕业生。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize the association between the type of fellowship training and patient outcomes after hepatopancreatic (HP) cancer surgery across different surgeon career stages using a nationally representative cohort of Medicare beneficiaries. BACKGROUND: The current state of training in hepato-pancreato-biliary (HPB) surgery in North America is defined through 3 main pathways: the Complex General Surgical Oncology (CGSO), the Americas HPB Association fellowship, and the American Society of Transplant Surgeons fellowship. Each pathway offers a unique perspective on HPB surgery with a different number of training years, yet outcomes of graduates performing HP surgery relative to the type of fellowship training have not been defined. METHODS: Medicare claims were used to identify patients who underwent HP surgery for cancer between 2016 and 2021. The association of textbook outcomes (TOs), defined as no postoperative complications, no prolonged length of stay, no 90-day mortality, and no 90-day readmission, relative to different fellowship pathways was examined. RESULTS: Overall, 15,411 cancer operations (pancreatectomy: 11,003, 71.4%; hepatectomy: 4408, 28.6%) were performed by 1030 HPB surgeons. A total of 9390 patients (60.9%) were operated on by a CGSO/surgical oncology graduate, 2315 patients (15.0%) by a HPB fellowship graduate, and 3706 (24.1%) by a transplant fellowship graduate. Patients who were operated on by a HPB fellowship graduate more frequently had a higher Charlson score (>5: 44.8% vs 38.1%) and more frequently were operated on an urgent basis (7.7% vs 6.1%) compared with individuals treated by CGSO/surgical oncology graduates (both P <0.001). After adjusting for patient, procedure, hospital, and surgeon-related factors, the likelihood of TO after a HP operation by a HPB fellowship graduate was 47.7% versus 45.2% among CGSO (% difference: 2.5%) and 42.8% among transplant fellowship graduates (% difference: 4.9%, P = 0.001). Differences in TO were mostly attributable to differences in outcomes after pancreatectomy ( P <0.001) rather than hepatectomy ( P = 0.758). While the probability of TO was higher among surgeons having completed a dedicated HPB fellowship during the early (1st-7th year of independent practice, P = 0.032) and middle (8th-14th year, P < 0.001) career stages, the probability of TO did not differ based on fellowship type among late-career surgeons (≥15th year, P = 0.257). CONCLUSIONS: Achievement of TO following a HP cancer procedure was higher among surgeons who had completed a dedicated HPB fellowship, especially during early and middle career stages. Further efforts should be made to enhance HP surgery exposure and training for CGSO fellows interested in a career in HPB surgery.
引用
- Tsilimigras DI, Chatzipanagiotou OP, Woldesenbet S, et al. Hepato-pancreato-biliary Surgery: Analysis of Outcomes Among Graduates of Different Fellowship Pathways. Ann Surg. 2024. PMID: 39660445. doi:10.1097/SLA.0000000000006602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。